GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **3576 - 3600** of **4050** in total

« First

‹ Prev

…

140

141

142

143

144

145

146

147

148

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▼
IgM	Patient 1	6	moderate	G82348BZ	37
IgG	Patient 2	3	mild	G82348BZ	37
IgG	Patient 2	3	mild	G86566MF	37
IgG	Patient 3	-180	mild	G25473LQ	37
IgG	Patient 3	-180	mild	G38488WF	37
IgG	Patient 3	4	mild	G17390SF	37
IgG	Patient 3	4	mild	G63074CQ	37
IgG	Patient 1	22	moderate	G03499BP	36
IgG	Patient 1	22	moderate	G21675ZL	36
IgG	Patient 1	22	moderate	G31265MS	36
IgG	Patient 1	22	moderate	G84224TW	36
IgG	Patient 1	6	moderate	G03499BP	36
IgM	Patient 1	10	moderate	G17266GE	36
IgM	Patient 1	10	moderate	G84224TW	36
IgM	Patient 1	22	moderate	G82204SH	36
IgG	Patient 2	15	mild	G08520NM	36
IgG	Patient 2	15	mild	G40696TO	36
IgG	Patient 2	15	mild	G86566MF	36
IgM	Patient 1	6	moderate	G00052MO	36
IgM	Patient 1	6	moderate	G25473LQ	36
IgG	Patient 2	3	mild	G82204SH	36
IgG	Patient 3	-180	mild	G21320TF	36
IgG	Patient 3	11	mild	G00053MO	36
IgG	Patient 3	11	mild	G39213VZ	36
IgG	Patient 3	4	mild	G29857RC	36